Total Payments
$128,454
2024 Payments
$15,355
Companies
63
Transactions
2,085
Medicare Patients
562
Medicare Billing
$68,028
Payment Breakdown by Category
Other$91,887 (71.5%)
Food & Beverage$29,548 (23.0%)
Travel$3,529 (2.7%)
Gifts$2,670 (2.1%)
Education$820.69 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,887 | 68 | 71.5% |
| Food and Beverage | $29,548 | 1,985 | 23.0% |
| Travel and Lodging | $3,529 | 19 | 2.7% |
| Gift | $2,670 | 1 | 2.1% |
| Education | $820.69 | 12 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $51,388 | 217 | $0 (2024) |
| Allergan, Inc. | $19,682 | 121 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $17,147 | 85 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $12,754 | 74 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $8,015 | 585 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $4,148 | 83 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,166 | 103 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $1,131 | 59 | $0 (2022) |
| Lilly USA, LLC | $1,035 | 69 | $0 (2024) |
| PFIZER INC. | $868.14 | 69 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,355 | 297 | ABBVIE INC. ($11,059) |
| 2023 | $17,449 | 268 | AbbVie Inc. ($13,811) |
| 2022 | $32,883 | 364 | Biohaven Pharmaceutical Holding Company Ltd. ($17,147) |
| 2021 | $31,086 | 367 | AbbVie Inc. ($14,079) |
| 2020 | $20,823 | 292 | Allergan, Inc. ($18,219) |
| 2019 | $2,463 | 168 | Teva Pharmaceuticals USA, Inc. ($749.79) |
| 2018 | $5,481 | 164 | Novartis Pharmaceuticals Corporation ($2,791) |
| 2017 | $2,913 | 165 | Teva Pharmaceuticals USA, Inc. ($813.03) |
All Payment Transactions
2,085 individual payment records from CMS Open Payments — Page 1 of 84
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: PAIN | ||||||
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $115.05 | General |
| Category: Neuroscience | ||||||
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.13 | General |
| Category: Neuroscience | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $4.67 | General |
| Category: Narcoplepsy | ||||||
| 12/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.76 | General |
| Category: Narcoplepsy | ||||||
| 12/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $11.97 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: PAIN | ||||||
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.29 | General |
| 12/05/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neurology | ||||||
| 12/04/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Central Nervous System | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: PAIN | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| Category: Narcoplepsy | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 136 | 169 | $41,803 | $14,675 |
| 2022 | 5 | 145 | 165 | $38,549 | $16,970 |
| 2021 | 5 | 155 | 196 | $47,825 | $21,035 |
| 2020 | 4 | 126 | 146 | $40,075 | $15,348 |
Total Patients
562
Total Services
676
Medicare Billing
$68,028
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 47 | $14,100 | $5,778 | 41.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $10,800 | $3,875 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 30 | $7,500 | $2,345 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $4,725 | $1,479 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 17 | $2,278 | $623.10 | 27.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 24 | $2,400 | $574.25 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 52 | $13,000 | $6,282 | 48.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $14,000 | $5,761 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 30 | $6,000 | $2,543 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 37 | $4,625 | $1,965 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $924.00 | $419.11 | 45.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 67 | $16,750 | $8,313 | 49.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 46 | 46 | $18,400 | $7,460 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 40 | $8,000 | $3,519 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 15 | $1,875 | $1,037 | 55.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 13 | 28 | $2,800 | $706.06 | 25.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 51 | 66 | $16,500 | $6,865 | 41.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 36 | 36 | $14,400 | $4,981 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 28 | $5,600 | $2,010 | 35.9% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 16 | 16 | $3,575 | $1,492 | 41.7% |
About Dr. Winthrop Risk, MD
Dr. Winthrop Risk, MD is a Neurology healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104804053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Winthrop Risk, MD has received a total of $128,454 in payments from pharmaceutical and medical device companies, with $15,355 received in 2024. These payments were reported across 2,085 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,887).
As a Medicare-enrolled provider, Risk has provided services to 562 Medicare beneficiaries, totaling 676 services with total Medicare billing of $68,028. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cedar Rapids, IA
- Active Since 01/01/2006
- Last Updated 04/20/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104804053
Products in Payments
- UBRELVY (Drug) $48,443
- NURTEC ODT (Drug) $30,531
- QULIPTA (Drug) $21,201
- GILENYA (Drug) $2,895
- AJOVY (Biological) $2,367
- Austedo XR (Drug) $1,694
- AUSTEDO (Drug) $1,603
- VRAYLAR (Drug) $993.12
- TROKENDI XR (Drug) $973.63
- AJOVY (Drug) $818.28
- NUEDEXTA (Drug) $801.05
- EMGALITY (Drug) $788.25
- COPAXONE (Drug) $775.83
- KESIMPTA (Drug) $740.38
- Aimovig (Biological) $643.93
- NUPLAZID (Drug) $625.86
- ZEPOSIA (Drug) $571.08
- Wakix (Drug) $488.67
- Sunosi (Drug) $419.88
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $409.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cedar Rapids
Dr. Scott Geisler, Md, MD
Neurology — Payments: $59,256
Neurology $59,256
Robert Struthers, Md, MD
Neurology — Payments: $2,492
Neurology $2,492
Dr. Laurence Krain, Md, MD
Neurology — Payments: $2,442
Neurology $2,442
Shereen Chang, Md, MD
Neurology — Payments: $2,314
Neurology $2,314
Dr. Thomas Rogers, Do, DO
Neurology — Payments: $1,547
Neurology $1,547
Dr. Andrew Peterson, Md, MD
Neurology — Payments: $1,090
Neurology $1,090